ArticleEClinicalMedicine2026

GLP-1 receptor agonist and risk of erectile dysfunction in men with type 2 diabetes: a target trial emulation.

Huilin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.